Rare-disease and pulmonary therapeutics
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Bridgewater | 49 | New buy | 295,579 | $48,333,078 | 0.2% |
| Ancora | 38 | Holds (flat) | 214 | $34,993 | 0.0% |
| Darwin Global Management, Ltd. (auto-surfaced) | 38 | Trimmed -20% | 16,805,184 | $2,576,570,811 | 68.3% |
| Stanley Druckenmiller / Duquesne | 81 | Trimmed -22% | 1,154,090 | $188,717 | 5.6% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-06-27.